EBAC

European Biotech Acquisition Corp.

USD

	Dec '21	Dec '22
average inventory
average payables		208.72K -
average receivables
book value per share		9.50 -
capex per share
capex to depreciation
capex to operating cash flow
capex to revenue
cash per share		0.02 -
days of inventory on hand
days payables outstanding
days sales outstanding
debt to assets	0.06 -	0.07 11.20%
debt to equity	0.06 -	0.07 11.99%
dividend yield
earnings yield		0.92 -
enterprise value	-868.28K -	3.49M 502.22%
enterprise value over ebitda	0.24 -	-0.58 347.46%
ev to operating cash flow	1.26 -	-6.78 638.21%
ev to sales
free cash flow per share		-0.04 -
free cash flow yield		-0.14 -
graham net net		-0.65 -
graham number		7.66 -
income quality	-0.47 -	-1.50 222.28%
intangibles to total assets	0 -	0
interest coverage
interest debt per share
inventory turnover
invested capital
market cap		3.80M -
net current asset value	-6.69M -	-8.19M 22.36%
net debt to ebitda	0.24 -	0.05 78.14%
net income per share		0.27 -
operating cash flow per share		-0.04 -
payables turnover
receivables turnover
research and ddevelopement to revenue
return on tangible assets	0.03 -	0.03 14.49%
revenue per share
roe	0.03 -	0.03 13.89%
roic	-0.02 -	-0.22 838.62%
sales general and administrative to revenue
shareholders equity per share		9.50 -
stock based compensation to revenue
tangible asset value	120.86M -	121.20M 0.28%
tangible book value per share		9.50 -
working capital	411.27K -	-438.93K 206.73%

All numbers in USD (except ratios and percentages)